UBS analyst Douglas Schenkel assumes coverage on Repligen (NASDAQ: RGEN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE